
You are here

Topics:
Expertise
Health financing and payment, results-based financing, social protection, conditional cash transfer programs, noncommunicable disease, maternal and child health
Bio
Amanda Glassman is chief operating officer and senior fellow at the Center for Global Development and also serves as secretary of the board. Her research focuses on priority-setting, resource allocation and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at the Center from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world.
Prior to joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015 and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and coauthor of the books Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development 2016), From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010), and The Health of Women in Latin America and the Caribbean (World Bank 2001).
More From Amanda Glassman
This is a joint post with Andy Sumner, and it originally appeared on The Guardian's Poverty Matters Blog.
What do the EU, the Global Fund for Aids, TB and Malaria, and the World Bank's International Development Association have in common? All of them want to save money during a fiscal crunch by cutting off aid to middle-income countries (MIC).
After a decade of rapid economic growth, many developing countries have attained middle-income status, but poverty reduction in these countries has not kept pace with economic growth. Most of the world’s poor—up to a billion people—now live in these new middle-income countries. These countries also carry the majority of the global disease burden.
The United States budget for 2011; red area is global health aid (Source: xkcd)
This is a joint post with Amanda Glassman.
The verdict is out (sort of): the proposed total global health appropriation for FY2012 will be $8.3 billion; $600m less than 2011 appropriations, $38.3m higher than the enacted amount in 2011 and $1.5 billion less than requested funding. More than $5.5 billion of this funding is appropriated to HIV/AIDS; $1.05 billion of which are contributions to the Global Fund. A further $2.6 billion is appropriated for USAID to fulfill a portfolio of responsibilities from nutrition to HIV/AIDS treatment and prevention. Some highlights:
The Center for Global Development invites you to a brownbag onHealth Care Utilization, Socioeconomic Factors and Child Health in India
FeaturingAlok Bhargava Professor of Economics University of Houston
Hosted byAmanda Glassman Director of Global Health Policy and Research Fellow Center for Global Development
Wednesday, December 7, 2011 12:00pm – 1:30 pm
at Center for Global Development 1800 Massachusetts Avenue, NW, Third Floor, Washington, DC *Please bring photo identification*
CGD is please to host Alok Bhargava to discuss his work on child health and healthcare utilization patterns in India. Demographic surveys have been used to provide meaningful information on the health status for women and children world-wide. Dr. Bhargava’s work evaluates demographic survey information to evaluate the effects of public and private health care service utilization, food consumption patterns and maternal health status on child health indicators such as child weight, height, and hemoglobin concentration. Dr. Bhargava’s analysis finds that children’s heights and weight showed beneficial effects of child vaccinations against DPT, polio and measles, and negative effects of not utilizing government health facilities. The models for children’s hemoglobin concentration indicated beneficial effects of food consumption patterns and treatment against intestinal parasites. The results provide several insights for improving child health in India. Recommendations include the scale up of immunization coverage and chemotherapy treatments for removing intestinal parasites for Indian children, and investments in public health care to increase the uptake of health care services in rural areas.
The full paper can be accessed here.
The Center for Strategic and International Studies presentsConference on the Strategic Power of Vaccines
Featuring keynote speaches from:Rajiv Shah Administrator U.S. Agency for International Development
Anthony Fauci Director National Institute of Allergy and Infectious Diseases, NIH
And panel discussions including:Helen Evans, GAVI AllianceAdmiral William FallonMarkus Geisser, International Committee of the Red CrossJulie Gerberding, Merck VaccinesAmanda Glassman, Center for Global DevelopmentJohn Hamre, CSISOrin Levine, Johns Hopkins Bloomberg School of Public HealthMargaret McGlynn, International AIDS Vaccine InitiativeJ. Stephen Morrison, CSISRegina Rabinovich, Bill & Melinda Gates FoundationAnne Schuchat, CDCEric Schwartz, U. of Minnesota Humphrey School of Public Affairs
Friday, December 9, 2011 9:00am – 2:00pm
Willard Intercontinental Hotel 1401 Pennsylvania Avenue NW Washington, DC
The second CSIS High-Level Forum on U.S. Leadership in Global Health will place a focus on vaccines as instruments of U.S. global leadership in pursuit of security and economic interests at home and abroad, in close enduring partnerships with corporations, foundations, multilateral organizations, and other countries. This conference grows out of the remarkable surge of interest in vaccines in public health efforts worldwide as well as the heightened grasp of the complexities of global immunization efforts.
Commentary Menu